STRS Ohio’s MaxCyte MXCT Stock Holding History

STRS Ohio’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$91K	Hold	129,500	–	–	﹤0.01%	1805
2025 Q4	$201K	Hold	129,500	–	–	﹤0.01%	1514
2025 Q3	$205K	Hold	129,500	–	–	﹤0.01%	1521
2025 Q2	$282K	Buy	129,500 +9,200	+8%	+$22.3K	﹤0.01%	1531
2025 Q1	$328K	Hold	120,300	–	–	﹤0.01%	1364
2024 Q4	$500K	Hold	120,300	–	–	﹤0.01%	1205
2024 Q3	$468K	Hold	120,300	–	–	﹤0.01%	1296
2024 Q2	$472K	Buy	120,300 +12,300	+11%	+$52.9K	﹤0.01%	1284
2024 Q1	$452K	Sell	108,000 -6,900	-6%	-$32.4K	﹤0.01%	1313
2023 Q4	$540K	Sell	114,900 -6,300	-5%	-$24.5K	﹤0.01%	1247
2023 Q3	$378K	Hold	121,200	–	–	﹤0.01%	1379
2023 Q2	$556K	Buy	121,200 +4,700	+4%	+$21.6K	﹤0.01%	1224
2023 Q1	$576K	Buy	116,500 +27,700	+31%	+$136K	﹤0.01%	1219
2022 Q4	$484K	Buy	88,800 +28,300	+47%	+$174K	﹤0.01%	1337
2022 Q3	$393K	Buy	60,500 +35,700	+144%	+$199K	﹤0.01%	1411
2022 Q2	$117K	Hold	24,800	–	–	﹤0.01%	1733
2022 Q1	$173K	Buy	24,800 +21,200	+589%	+$145K	﹤0.01%	1740
2021 Q4	$36K	Hold	3,600	–	–	﹤0.01%	2051
2021 Q3	$43K	Buy	+3,600	New	+$54.3K	﹤0.01%	2093

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

STRS Ohio's MXCT Position: Q1 2026 in Review

STRS Ohio held its MaxCyte (MXCT) position steady in Q1 2026 at 129,500 shares worth $91K. The position accounts for ﹤0.01% of the portfolio, ranked #1805.

STRS Ohio first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $576K in Q1 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

STRS Ohio held 129,500 shares of MaxCyte worth $91K as of Q1 2026.
STRS Ohio left its MaxCyte share count unchanged in Q1 2026.
MaxCyte made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1805 holding.
STRS Ohio first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
STRS Ohio's MaxCyte position peaked at $576K in Q1 2023.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.